APOE and metabolic syndrome: With the aim of testing whether hidrosmin can effectively affect the development of diabetic renal disease, we induced T1D by STZ injection in ApoE KO mice, a model of combined hyperglycemia and dyslipidemia that develops accelerated renal injury and resembles the morphology seen in DN patients [28].